MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/neurosci6040131

Медицинская библиотека · NeuroSci · 2025

Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin.

Roca Elisa, Roca Elena, Cucinella Alessandra, Madonia Giorgio, Centonze Giovanni, Lombardo Fiorella, Martinelli Licia, Damiani Maria Elisa, Santo Antonio

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Innovative treatments for lung cancer patients have significantly improved their lives. Therefore, patients who develop brain metastases are more likely to require management of quality of life (QoL) by reducing pathological decline in brain function. New therapeutic strategies have allowed us to manage brain metastases, thanks to the ability to cross the blood-brain barrier. Moreover, new molecules have been designed as adjuvants to standard treatments for the management of cancer patients with brain metastases.

METHODS

We implemented a descriptive, observational, retrospective study. Therefore, we consecutively collected the data of eighty-six (N  =  86) patients admitted to our department (April 2020-April 2025) diagnosed with brain involvement in a thoracic neoplasm and treated with silibinin, in association with standard treatment. The main endpoint of our analysis is to define the safety profile of silibinin and to evaluate its eventual benefits in terms of QoL.

RESULTS

Silibinin was well tolerated (only one mild adverse event was reported); furthermore, patients taking silibinin had a good quality of life that was maintained over a long period of time, and in some cases, an improvement in neurological symptoms and overall patient well-being was also documented.

CONCLUSIONS

Our study is the first collection of a large number of lung cancer patients with brain metastasis taking silibinin, which is very well tolerated and allows patients to maintain a good QoL.

Для цитирования: Roca Elisa, Roca Elena, Cucinella Alessandra, Madonia Giorgio, Centonze Giovanni, Lombardo Fiorella, Martinelli Licia, Damiani Maria Elisa, Santo Antonio. Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin.. NeuroSci. 2025. DOI: 10.3390/neurosci6040131.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.